Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Director's Dealing 2013

Feb 5, 2013

32853_dirs_2013-02-05_6cd9fa40-6f1f-4de1-96f7-dbf7b486f176.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2013-02-01

Reporting Person: JONES ROBERT C (EVP, RESEARCH & DEVELOPMENT)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-02-01 Common Stock M 208 $4.4461 Acquired 208 Direct
2013-02-01 Common Stock S 208 $16.6601 Disposed 0 Direct
2013-02-01 Common Stock M 6729 $4.4461 Acquired 6729 Direct
2013-02-01 Common Stock S 6729 $16.6107 Disposed 0 Direct
2013-02-04 Common Stock M 47 $4.4461 Acquired 47 Direct
2013-02-04 Common Stock S 47 $16.51 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-02-01 Employee Stock Option (Right to Buy) $4.4461 M 208 Disposed 2018-04-23 Common Stock (208) Direct
2013-02-01 Employee Stock Option (Right to Buy) $4.4461 M 6729 Disposed 2018-04-23 Common Stock (6729) Direct
2013-02-04 Employee Stock Option (Right to Buy) $4.4461 M 47 Disposed 2018-04-23 Common Stock (47) Direct

Footnotes

F1: The sales reported by Mr. Jones were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2012.

F2: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $16.40 to $16.77, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

F3: The shares subject to the Option fully vested on March 22, 2010.

F4: The Option was originally granted on April 23, 2008 and was re-granted on December 23, 2009 as part of the Issuer's option repricing. 6,089 shares subject to the Option were vested as of the re-grant date, an additional 1,652 shares vested on December 31, 2011 and 172 shares vest monthly thereafter.